Lys Therapeutics Raises More Than €25 Million to Advance LYS241 Toward Clinical Development in Neurology
Financing includes a grant of more than $5 million from The Michael J. Fox Foundation to advance a first-in-class neurovascular antibody across major neurological indications LYON and CAEN, France, June 22, 2026 /PRNewswire/ -- Lys Therapeutics, a French biotechnology company pioneering a...
Financing includes a grant of more than $5 million from The Michael J. Fox Foundation to advance a first-in-class neurovascular antibody across major neurological indications LYON and CAEN, France, June 22, 2026 /PRNewswire/ -- Lys Therapeutics, a French biotechnology company pioneering a...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.